1. Nicolay U, Heijnen E, Nacci P, Patriarca PA, Leav B. Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience. Int J Infect Dis. 2019;85:S1-S9.
2. Essink B, Fierro C, Rosen J, Figueroa AL, Zhang B, Verhoeven C, et al. Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59- adjuvanted trivalent influenza vaccines in older adults. Vaccine. 2020;38(2):242-50.
3. Aguado TM, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017. Vaccine. 2018;36(7):921-31.
4. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428-36.
5. Loubet P, Loulergue P, Galtier F, Launay O. Seasonal influenza vaccination of high-risk adults. Expert Rev Vaccines. 2016;15(12):1507-18.
6. Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, et al. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 2015;82(1):50-5.
7. Ray R, Dos Santos G, Buck PO, Claeys C, Matias G, Innis BL, et al. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Hum Vaccin Immunother. 2017;13(7):1640-52.
8. Ferdinands JM, Fry AM, Reynolds S, Petrie JG, Flannery B, Jackson ML, et al. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011–2012 through 2014–2015. Clin Infect Dis. 2017;64(5):544-50.
9. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36-44.
10. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2018(2):Art. No.:CD004879.
11. Turner N, Pierse N, Bissielo A, Huang QS, Radke S, Baker M, et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill. 2014;19(34):20884.
12. Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018(2):Art.No.:CD001269.
13. Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, et al. The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people. J Infect Dis. 2017;216(4):405-14.
14. Beyer WEP, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030-3.
15. Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H, et al. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: An individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017;5(3):200- 11.
16. Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas Roger E, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018(2):Art.No.:CD004876.
17. Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D. Effectiveness of MF59- adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. 2017;35(4):513-20.
18. Casado I, Domínguez A, Toledo D, Chamorro J, Force L, Soldevila N, et al. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Rev Vaccines. 2016;15(3):425-32.
19. Mosnier A, Daviaud I, Caini S, Berche H, Mansuy J-M, van der Werf S, et al. Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003–2014. Vaccine. 2017;35(16):2076-83.
20. MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102(24):1953-6
21. Heo JY, Song JY, Noh JY, Choi MJ, Yoon JG, Lee SN, et al. Effects of influenza immunization on pneumonia in the elderly. Hum Vaccin Immunother. 2018;14(3):744-9.
22. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis. JAMA. 2013;310(16):1711-20.
23. Puig-Barbera J, Diez-Domingo J, Varea AB, Chavarri GS, Rodrigo JAL, Hoyos SP, et al. Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine. 2007;25(42):7313-21.
24. Lee W-J, Chen L-K, Tang G-J, Lan T-Y. The impact of influenza vaccination on hospitalizations and mortality among frail older people. J Am Med Dir Assoc. 2014;15(4):256-60.
25. Gill TM, Allore HG, Holford TR, Guo Z. Hospitalization, restricted activity, and the development of disability among older persons. JAMA. 2004;292(17):2115-24.
26. Brummel NE, Balas MC, Morandi A, Ferrante LE, Gill TM, Ely EW. Understanding and reducing disability in older adults following critical illness. Crit Care Med. 2015;43(6):1265-75.
27. Turner N, Pierse N, Bissielo A, QS H, Baker M, Widdowson M-A, et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine. 2014;32(29):3687-93.
28. Bissielo A, Pierse N, Huang Q, Thompson M, Kelly H, Mishin V, et al. Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: Interim estimates. Euro Surveill. 2016;21(1):30101.
29. Pierse N, Kelly H, Thompson MG, Bissielo A, Radke S, Huang QS, et al. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non- influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2016;34(4):503-9.
30. Institute of Environmental Science and Research Ltd (ESR). Flu surveillance and research [Internet]. Wellington: Institute of Environmental Science and Research Ltd (ESR); 2020 [updated 2020 November; cited 2020 December 11]. Available from: https://www.esr.cri.nz/our-services/ consultancy/flu-surveillance-and-research/
31. Kunzel W, Engelmann H, D’Hondt E. Immune response to influenza vaccination. Lancet. 1994;343(8890):173.
32.Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med.2014;371(10):918-31.
33.Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study. Vaccine. 2016; 34(32):3649-56.
34.Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165(2):104-11.
35. Poehling K, Szilagyi P, Staat M, Snively B, Payne D, Bridges C, et al. Impactof maternal immunization on influenza hospitalizations in infants. Am J ObstetGynecol. 2011;204(Suppl 6):S141-8.
36.Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3years: An observational cohort study. Lancet Infect Dis. 2011;11(1):23-9.
37.Flannery B, Reynolds SB, Blanton L, Santibanez TA, O’Halloran A, Lu P-J, et al. Influenza vaccine effectiveness against pediatric deaths: 2010–2014.Pediatrics. 2017;139(5):e20164244.
38.Blythe C, Macartney K, Hewagama S, Senenayake S, Friedman N, Simpson G, et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: The Influenza Complications Alert Network (FluCAN). Euro Surveill. 2016;21(30):30301.
39.Rodrigues BS, David C, Costa J, Ferreira JJ, Pinto FJ, Caldeira D. Influenza vaccination in patients with heart failure: A systematic review and meta-analysis of observational studies. Heart. 2020;106(5):350-7.
40.Wang IK, Lin C-L, Chang Y-C, Lin P-C, Liang C-C, Liu Y-L, et al. Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study. Vaccine. 2013;31(4):718-24.
41.Gershon AS, Chung H, Porter J, Campitelli MA, Buchan SA, Schwartz KL, et al. Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease. J Infect Dis.2020;221(1):42-52.
42.Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: A meta-analysis of case-control studies. Heart. 2015;101(21):1738-47.
43.Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: Review of evidence. Expert Rev Vaccines. 2017;16(7):723-36.
44.Shinjoh M, Sugaya N, Yamaguchi Y, Iibuchi N, Kamimaki I, Goto A, et al. Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season. Vaccine.2018;36(37):5510-8.
45.Bartoszko JJ, McNamara IF, Aras OAZ, Hylton DA, Zhang YB, Malhotra D, et al. Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. Vaccine. 2018;36(24):3434-44.
46.Lapi F, Marconi E, Simonetti M, Baldo V, Rossi A, Sessa A, et al. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly. Expert RevVaccines. 2019;18(6):663- 70.
47.Cheng AC, Macartney KK, Waterer GW, Kotsimbos T, Kelly PM, Blyth CC, et al. Repeated vaccination does not appear to impact upon influenza vaccine effectiveness against hospitalization with confirmed influenza. Clin InfectDis. 2017;64(11):1564-72.
48.Lin H-C, Chiu H-F, Ho S-C, Yang C-Y. Association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: A population-based case-control study. Int J Environ Res Public Health. 2014;11(4):3639.
49.Chiang M-H, Wu H-H, Shih C-J, Chen Y-T, Kuo S-C, Chen T-L. Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients. Am Heart J. 2017;193(Nov):1-7.
50.Fang Y-A, Chen C-I, Liu J-C, Sung L-C. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: A population-based cohort study. Acta Cardiol Sin. 2016;32(3):290-8.
51.Chen C-I, Kao P-F, Wu M-Y, Fang Y-A, Miser JS, Liu J-C, et al. Influenza vaccination is associated with lower risk of acute coronary syndrome in elderly patients with chronic kidney disease. Medicine. 2016;95(5):e2588.
52.Sung L-C, Chen C-I, Fang Y-A, Lai C-H, Hsu Y-P, Cheng T-H, et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study. Vaccine. 2014;32(30):3843-9.
53.Siriwardena AN, Gwini SM, Coupland CAC. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: Matched case-control study. Can Med Assoc J. 2010;182(15):1617-23.
54.Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation. 2021;144(18):1476- 1484
55. Modin D, Jorgensen ME, Gislason G, Jensen JS, Kober L, Claggett B, et al. Influenza vaccine in heart failure: Cumulative number of vaccinations, frequency, timing, and survival: A Danish nationwide cohort study. Circulation.2019;139(5):575-86.
